UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 141

Sortiert nach

A primer on medicinal cannabis safety and potential adverse effects

Australian journal of general practice, 2021-06, Vol.50 (6), p.345-350

Arnold, Jonathon C

2021

Volltextzugriff (PDF)

Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile

PloS one, 2013-07, Vol.8 (7), p.e70052-e70052

2013

Volltextzugriff (PDF)

The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence

Clinical and translational science, 2023-01, Vol.16 (1), p.10-30

2023

Volltextzugriff (PDF)

Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations

Scientific reports, 2021-07, Vol.11 (1), p.14948-14948, Article 14948

2021

Volltextzugriff (PDF)

Access to cannabidiol without a prescription: A cross-country comparison and analysis

The International journal of drug policy, 2020-11, Vol.85, p.102935-102935, Article 102935

2020

Volltextzugriff (PDF)

Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)

Harm reduction journal, 2020-06, Vol.17 (1), p.37-12, Article 37

2020

Volltextzugriff (PDF)

Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats

PloS one, 2011-11, Vol.6 (11), p.e27237

2011

Volltextzugriff (PDF)

Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20)

Harm reduction journal, 2022-07, Vol.19 (1), p.1-88, Article 88

2022

Volltextzugriff (PDF)

Editorial: Cannabinoid interactions with ion channels, receptors, and the bio-membrane

Frontiers in physiology, 2023-05, Vol.14, p.1211230-1211230

2023

Volltextzugriff (PDF)

Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome

PloS one, 2023-01, Vol.18 (1), p.e0280842

2023

Volltextzugriff (PDF)

Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11

Frontiers in psychiatry, 2022-12, Vol.13, p.1048836-1048836

2022

Volltextzugriff (PDF)

Beyond CBD: Inhibitory effects of lesser studied phytocannabinoids on human voltage-gated sodium channels

Frontiers in physiology, 2023-02, Vol.14, p.1081186-1081186

2023

Volltextzugriff (PDF)

The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibit recombinant T-type channels

Frontiers in pharmacology, 2022-11, Vol.13, p.1048259-1048259

2022

Volltextzugriff (PDF)

Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice

PloS one, 2012-04, Vol.7 (4), p.e34129

2012

Volltextzugriff (PDF)

MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy

Frontiers in physiology, 2023-04, Vol.14, p.1086243-1086243

2023

Volltextzugriff (PDF)

Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22)

Harm reduction journal, 2024-05, Vol.21 (1), p.104-104, Article 104

2024

Volltextzugriff (PDF)

An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma

Cancers, 2022-08, Vol.14 (15), p.3813

2022

Volltextzugriff (PDF)

The Heat Sensing Trpv1 Receptor Is Not a Viable Anticonvulsant Drug Target in the Scn1a+/− Mouse Model of Dravet Syndrome

Frontiers in pharmacology, 2021-05, Vol.12, p.675128-675128

2021

Volltextzugriff (PDF)

Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial

BMJ open, 2020-05, Vol.10 (5), p.e034421-e034421

2020

Volltextzugriff (PDF)

Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus

Addiction biology, 2010-10, Vol.15 (4), p.448-463

2010

Volltextzugriff (PDF)

Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey

Journal of cannabis research, 2023-09, Vol.5 (1), p.35-35, Article 35

2023

Volltextzugriff (PDF)

Ictal vocalizations in the Scn1a+/− mouse model of Dravet syndrome

Epilepsia open, 2023-09, Vol.8 (3), p.776-784

2023

Volltextzugriff (PDF)

Sex-specific transcriptomic and epitranscriptomic signatures of PTSD-like fear acquisition

iScience, 2022-09, Vol.25 (9), p.104861-104861, Article 104861

2022

Volltextzugriff (PDF)

Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome

Journal of cannabis research, 2022-01, Vol.4 (1), p.2-2, Article 2

2022

Volltextzugriff (PDF)

Inhibition of human recombinant T‐type calcium channels by phytocannabinoids in vitro

British journal of pharmacology, 2022-08, Vol.179 (15), p.4031-4043

2022

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(129)

Publikationsform

Sprache

Englisch
(141)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A primer on medicinal cannabis safety and potential adverse effects

Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile

The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence

Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations

Access to cannabidiol without a prescription: A cross-country comparison and analysis

Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)

Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats

Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20)

Editorial: Cannabinoid interactions with ion channels, receptors, and the bio-membrane

Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome

Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11

Beyond CBD: Inhibitory effects of lesser studied phytocannabinoids on human voltage-gated sodium channels

The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibit recombinant T-type channels

Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice

MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy

Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22)

An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma

The Heat Sensing Trpv1 Receptor Is Not a Viable Anticonvulsant Drug Target in the Scn1a+/− Mouse Model of Dravet Syndrome

Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial

Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus

Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey

Ictal vocalizations in the Scn1a+/− mouse model of Dravet syndrome

Sex-specific transcriptomic and epitranscriptomic signatures of PTSD-like fear acquisition

Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome

Inhibition of human recombinant T‐type calcium channels by phytocannabinoids in vitro

Suchergebnisse filtern